Virbac SA (EUR)
VIRP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range213.00 | 217.00
52-Wk Range- | -
Last Close217.00
Mkt Cap (m)1,830.34
Dividend yield-
ISINFR0000031577
Volume3,283.00
Exchange VenuePAR

Company Profile

Virbac SA is a major drug manufacturer focusing on animal health. The company provides medicines feed supplements for animals. It operates in various therapeutic segments like Parasiticides, Disinfectants & Sanitizer, Hormones, Antibacterial, and Topical.

Key Information
Price/Earning25.35
Price/Book3.34
Price/Sales1.92
P/CF12.53
Rev Growth (3 year avg)2.48
EPS Growth (3 year avg)0.14
Operating Margin % 11.31
Net Margin %5.49
Return on Equity10.54
Debt/Equity0.89

Documents

Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.virbac.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)773.12852.62871.83861.88868.93938.34
Operating Income (m)109.5641.7068.2265.4975.88106.11
Net Income (m)63.609.4134.65-2.5820.1051.55
Basic EPS7.541.124.11-0.312.396.11
Avg. Diluted Shares Outstanding (m)8.438.438.438.428.428.43
Balance Sheet
EUR201420152016201720182019
Current Assets (m)750.80485.50433.51400.63407.55450.87
Non Current Assets (m)575.04945.05983.65876.70865.26872.39
Total Assets (m)1,325.841,430.551,417.161,277.331,272.811,323.26
Current Liabilities (m)558.33364.08393.10328.50331.27372.49
Total Liabilities (m)------
Total Equity (m)430.93438.41473.63436.35460.31517.78
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)76.4546.22142.45107.8183.62131.61
Capital Expenditure (m)-40.11-42.54-40.03-38.24-33.87-22.99
Figures are quoted in EUR unless stated otherwise
-
No change
217.00
Last Price